Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...
With a trio of executive orders, President Donald Trump has almost instantly thrown the world economy and his own goal of ...
Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...
A New York appellate court has upheld drug convictions for two Cayuga County defendants, Marcus Brumberger and Jamel Nellons, ...
PEOPLE revisits the cover story about Philip Seymour Hoffman's death, 11 years after he died unexpectedly of acute mixed drug ...
Tariffs may sound tough, but America’s fentanyl crisis stems from a decades-long addiction problem that trade policy can’t ...
Trump knows the United States has more leverage over its neighbors than they do over his country. But exploiting that ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...
Officers stopped a vehicle for driving without headlights at 6:30 p.m. on Jan. 13 on Columbia Road near Center Ridge Road.
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...